Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ John Wiley & Sons Inc. (WLY) Stock Forecast & Price Prediction United States | NYSE | Communication Services | Publishing
$36.71
+0.36 (0.99%)Did WLY Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if Wiley is one of their latest high-conviction picks.
Based on our analysis of 2 Wall Street analysts, WLY has a bullish consensus with a median price target of $66.00 (ranging from $66.00 to $66.00). The overall analyst rating is Strong Buy (8.0/10). Currently trading at $36.71, the median forecast implies a 79.8% upside. This outlook is supported by 1 Buy, 0 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for WLY.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Sep 8, 2022 | CJS Securities | Daniel Moore | Market Outperform | Upgrade | $N/A |
| Aug 29, 2022 | CJS Securities | Daniel Moore | Market Perform | Downgrade | $N/A |
| Aug 25, 2020 | Stifel | Hold | Maintains | $N/A | |
| Mar 5, 2020 | Stifel | Hold | Maintains | $N/A | |
| Sep 28, 2016 | Sidoti & Co. | Buy | Initiates | $N/A | |
| Apr 9, 2014 | Stifel Nicolaus | Hold | Downgrade | $N/A |
The following stocks are similar to Wiley based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
John Wiley & Sons Inc. has a market capitalization of $1.93B with a P/E ratio of 19.4x. The company generates $1.67B in trailing twelve-month revenue with a 9.2% profit margin.
Revenue growth is +1.3% quarter-over-quarter, while maintaining an operating margin of +16.4% and return on equity of +21.5%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Global publisher of academic and professional content.
The company generates revenue through the publication of scientific, technical, and medical journals, as well as educational materials for institutions and professionals. It also offers digital education products and resources tailored for higher education and professional training, which are essential for research and career development.
Founded in 1807, John Wiley & Sons has a strong reputation and extensive portfolio, including partnerships with academic institutions and societies. The company is actively engaged in digital transformation, enhancing its offerings to meet the evolving needs of the education and research sectors.
Communication Services
Publishing
5,200
Mr. Matthew S. Kissner
United States
2022
Here is how Scholastic (SCHL) and John Wiley & Sons (WLY) have performed compared to their sector so far this year.
Wiley (NYSE: WLY) reported Q3 results for the period ending January 31, 2026: Revenue rose 1% to $410M, Operating Income increased 21% to $63M, and EPS was $0.56, recovering from a loss of ($0.43) last year.
Wiley's revenue growth, improved operating income, and a turnaround in EPS signal financial stability and potential for future profitability, which can attract investor interest.
John Wiley & Sons, Inc. (WLY) held its Q3 2026 earnings call, providing insights into financial performance and business updates. Further details can be accessed in the full transcript.
The Q3 2026 earnings call provides insights into John Wiley & Sons' financial performance, growth strategies, and market position, crucial for assessing future investment potential.
Wiley (NYSE: WLY) has partnered with OpenEvidence to integrate its scientific and medical content into OpenEvidence's AI platform, enhancing resources for physicians at the point of care.
Wiley's partnership with OpenEvidence enhances its market position in medical AI, potentially increasing revenue streams and attracting more users, which could positively impact stock performance.
Wiley (NYSE: WLY, WLYB) will release Q3 2026 results on March 5, 2026, before market open, followed by a conference call at 10am ET. Webcast available on their Investor Relations site.
Wiley's third-quarter earnings release and conference call can influence stock performance, providing insights into financial health and future outlook, critical for investment decisions.
John Wiley & Sons reports margin improvement and growth in research sales, driven by AI licensing. However, it faces challenges in the learning segment. The company shows strong free cash flow and buybacks, with a combined yield near 13%.
WLY's margin improvement and AI licensing boost contrast with challenges in the learning segment, highlighting mixed performance but strong cash flow and attractive yields for investors.
Wiley will expand its Advanced Portfolio by launching eight new journals in life, health, and social sciences in 2026.
Wiley's expansion into life, health, and social sciences suggests growth potential and increased revenue opportunities, which could enhance investor confidence and stock performance.
Based on our analysis of 2 Wall Street analysts, John Wiley & Sons Inc. (WLY) has a median price target of $66.00. The highest price target is $66.00 and the lowest is $66.00.
According to current analyst ratings, WLY has 1 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $36.71. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict WLY stock could reach $66.00 in the next 12 months. This represents a 79.8% increase from the current price of $36.71. Please note that this is a projection by Wall Street analysts and not a guarantee.
The company generates revenue through the publication of scientific, technical, and medical journals, as well as educational materials for institutions and professionals. It also offers digital education products and resources tailored for higher education and professional training, which are essential for research and career development.
The highest price target for WLY is $66.00 from at , which represents a 79.8% increase from the current price of $36.71.
The lowest price target for WLY is $66.00 from at , which represents a 79.8% increase from the current price of $36.71.
The overall analyst consensus for WLY is bullish. Out of 2 Wall Street analysts, 1 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $66.00.
Stock price projections, including those for John Wiley & Sons Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.